Manufacturing quality and costs always play some part in the cost of a new drug, but they are the elephant in the room when looking at CAR-T, personalized cancer medications now under development.

President Donald Trump on Monday signed an executive order to incentivize prescription drug manufacturing in the U.S., streamlining the path for pharmaceutical companies to build new production sites ...

KALAMAZOO, MI – Pfizer Inc.'s Animal Health business is preparing to become a separate, free-standing company. But some decisions will have to be made about how that company, to be called Zoetis, will ...

(Bloomberg) -- Abbott Laboratories will make new investments in US manufacturing, with the impact of tariffs on medical devices and diagnostics looming over the industry. It expects to spend $500 ...

WASHINGTON (Reuters) -U.S. manufacturing moved closer to recovery in December, with production rebounding and new orders rising further, but the outlook remains uncertain amid the threat of higher ...